Home Compare EW vs JNJ
Stock Comparison · Structural lead, mixed market

Edwards Lifesciences vs Johnson & Johnson: Which Stock Looks Stronger in 2026?

Johnson & Johnson holds the cleaner structural position, with stability as the main driver and valuation adding further support. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.

Updated 2026-08-16

The result is anchored in stability, but valuation also reinforces the same direction. Johnson & Johnson leads by 11 points on the overall comparison score.

Trajectory Similarity
0.67
Moderately similar
Peer-set rank: #5
within Edwards Lifesciences Corporation's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The match is driven mainly by operating margin level and revenue stability.

Similarity drivers
operating margin levelrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EW
Edwards Lifesciences Corporation
44
Peer-Score
Signal qualityMedium
Peer basis: S&P 500
vs
JNJ
Johnson & Johnson
55
Peer-Score
Signal qualitylow
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: EW vs JNJ Profitability 57 53 Stability 47 88 Valuation 38 57 Growth 28 22 EW JNJ
Gap Ranking
#1 Stability +41
#2 Valuation +19
#3 Growth +6
#4 Profitability +4
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EW and JNJ Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EWJNJ Relative valuation Structural strength

Johnson & Johnson looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where EW and JNJ each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY EW Elevated · above norm 0th 50th 100th 25 pct gap JNJ Elevated · above norm 0th 50th 100th 74th 99th
Today EW sits in the upper-middle of its own 5-year history (74th percentile), while JNJ sits higher in its own history (99th). Within each stock's own 5-year context, EW is at a historically more favourable entry position than JNJ. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Stability
Both rank well on stability, but Johnson & Johnson still holds a clear edge.
Valuation
On valuation, Johnson & Johnson is positioned higher in the group, while Edwards Lifesciences Corporation is closer to the middle.
Stability — Dominant Gap
EW
47
JNJ
88
Gap+41in favour of JNJ

The stability gap is very wide, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

Edwards Lifesciences Corporation still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Stability is the clearest driver, and valuation also supports Johnson & Johnson's broader structural position.

Explore full peer positioning in AssetNext

Break down the EW vs JNJ comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-driven comparisons

Explore how EW and JNJ each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.